Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
2-[(3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl)-imino]-5-phosphono-pent-3-enoic acid
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is a synthetic small molecule belonging to the class of pyridoxamine 5'-phosphate analogs. It features a pyridine ring substituted with hydroxy, methyl, and phosphonomethoxy groups and is linked via an imine to a pentenoic acid backbone bearing two phosphonic acid groups. The compound has been cataloged in chemical databases as an experimental molecule but does not have any known approved medical indications or clinical trial activity. Its mechanism of action and pharmacological properties are not well characterized in the literature[2][7]. It is primarily referenced as a research chemical.
- Other names
- 2-[(3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl)-imino]-5-phosphono-pent-3-enoic acid(2E,3E)-2-[({3-hydroxy-2-methyl-5-(phosphonooxy)methyl]-4-pyridinyl}methyl)imino]-5-phosphono-3-pentenoic acid
02
Targets
CTH (Cystathionine gamma-lyase)
Beyond the preview
Go deeper on 2-[(3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl)-imino]-5-phosphono-pent-3-enoic acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 2-[(3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl)-imino]-5-phosphono-pent-3-enoic acid.